Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.

HOLON, Israel, April 6, 2016 /PRNewswire/ —

Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, announced today that Elliott Sigal, M.D., Ph.D., former Executive Vice President and Director of Bristol-Myers Squibb, has joined Compugen Ltd. as a strategic advisor….
Source: PRNewsWire-USA

Dr. Elliott Sigal Joins Compugen Ltd. as Strategic Advisor and Prof. Drew Pardoll Appointed Director at Compugen USA, Inc.